NTRK1 and hepatocellular carcinoma: SORA, as a multi-receptor tyrosine kinase inhibitor that can inhibit the proliferation of multiple tumor cells and promote cell apoptosis, is commonly used for the treatment of hepatocellular carcinoma clinically (Keating, 2017).